HSG Holding’s Beam Therapeutics BEAM Stock Holding History

HSG Holding’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-796,089	Closed	-$19.1M	–	20
2023 Q3	$19.1M	Hold	796,089	–	–	2.05%	11
2023 Q2	$25.4M	Hold	796,089	–	–	2.91%	11
2023 Q1	$24.4M	Hold	796,089	–	–	2.56%	9
2022 Q4	$31.1M	Hold	796,089	–	–	3.16%	9
2022 Q3	$37.9M	Hold	796,089	–	–	4.07%	8
2022 Q2	$30.8M	Hold	796,089	–	–	2.84%	9
2022 Q1	$45.6M	Hold	796,089	–	–	5.69%	6
2021 Q4	$63.4M	Hold	796,089	–	–	5.68%	6
2021 Q3	$69.3M	Hold	796,089	–	–	6.22%	6
2021 Q2	$102M	Hold	796,089	–	–	7.14%	6
2021 Q1	$63.7M	Sell	796,089 -331,845	-29%	-$31.6M	4.73%	7
2020 Q4	$92.1M	Hold	1,127,934	–	–	7.73%	5
2020 Q3	$27.8M	Hold	1,127,934	–	–	4.05%	6
2020 Q2	$31.6M	Buy	1,127,934 +7,399	+0.7%	+$159K	5.61%	5
2020 Q1	$20.2M	Buy	+1,120,535	New	+$24.4M	4.67%	7

Other funds holding BEAM

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

HSG Holding's BEAM Position: Q4 2023 in Review

HSG Holding sold out of Beam Therapeutics (BEAM) in Q4 2023, closing a stake of 796,089 shares — an estimated $19.1M sold.

HSG Holding first reported a position in BEAM in Q1 2020 and held it in 15 quarters. The position peaked at $102M in Q2 2021. 185 funds tracked by Wall St. Rank hold BEAM as of Q4 2023.

HSG Holding reported no remaining Beam Therapeutics position as of Q4 2023 after selling out during the quarter.
HSG Holding sold 796,089 Beam Therapeutics shares in Q4 2023, an estimated $19.1M.
HSG Holding first reported a position in Beam Therapeutics in Q1 2020 and held it in 15 quarters.
HSG Holding's Beam Therapeutics position peaked at $102M in Q2 2021.
185 funds tracked by Wall St. Rank held Beam Therapeutics as of Q4 2023.

Based on HSG Holding's 13F filing for Q4 2023, filed 14 Feb 2024.